From Antarctica to cancer research: a novel human DNA topoisomerase 1B inhibitor from Antarctic sponge Dendrilla antarctica

References

• Apavaloaei A, Hardy MP, Thibault P, Perreault C. The origin and immune recognition of tumor-specific antigens. Cancers (Basel) 2020;12:1404–13.
   PubMed Web of Science ®Google Scholar
• Haen SP, Löffler MW, Rammensee HG, Brossart P. Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire. Nat Rev Clin Oncol 2020;17:595–610.
   PubMed Web of Science ®Google Scholar
• Pommier Y, Nussenzweig A, Takeda S, Austin C. Human topoisomerases and their roles in genome stability and organization. Nat Rev Mol Cell Biol 2022;1–21.
   PubMed Web of Science ®Google Scholar
• Delgado JL, Hsieh CM, Chan NL, Hiasa H. Topoisomerases as anticancer targets. Biochem J 2018;475:373–98.
   PubMed Web of Science ®Google Scholar
• Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010;17:421–33.
   PubMed Web of Science ®Google Scholar
• Pommier Y. Drugging topoisomerases: lessons and challenges. ACS Chem Biol 2013;8:82–95.
   PubMed Web of Science ®Google Scholar
• Pommier Y. DNA topoisomerases and cancer. Cancer drug discovery and development. Humana Press; 2012.
   Google Scholar
• Chillemi G, Fiorani P, Benedetti P, Desideri A. Protein concerted motions in the DNA-human topoisomerase I complex. Nucleic Acids Res 2003;31:1525–35.
   PubMed Web of Science ®Google Scholar
• Stewart L, Redinbo MR, Qiu X, et al. A model for the mechanism of human topoisomerase I. Science (80-) 1998;279:1534–41.
   PubMed Web of Science ®Google Scholar
• Redinbo MR, Champoux JJ, Hol WG. Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry 2000;39:6832–40.
   PubMed Web of Science ®Google Scholar
• Soren BC, Dasari JB, Ottaviani A, et al. Topoisomerase IB: a relaxing enzyme for stressed DNA. Cancer Drug Resist 2019;3:18–25.
   Google Scholar
• Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006;6:789–802.
   PubMed Web of Science ®Google Scholar
• Beretta GL, Gatti L, Perego P, Zaffaroni N. Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug. Curr Med Chem 2013;20:1541–65.
   PubMed Web of Science ®Google Scholar
• Pommier Y, Barcelo JM, Rao VA, et al. Repair of topoisomerase I-mediated DNA damage. Prog Nucleic Acid Res Mol Biol 2006;81:179–229.
   PubMed Web of Science ®Google Scholar
• Tesauro C, Fiorani P, D’Annessa I, et al. Erybraedin C, a natural compound from the plant Bituminaria bituminosa, inhibits both the cleavage and religation activities of human topoisomerase I. Biochem J 2010;425:531–9.
   PubMed Web of Science ®Google Scholar
• Soren BC, Dasari JB, Ottaviani A, et al. In vitro and in silico characterization of an antimalarial compound with antitumor activity targeting human DNA topoisomerase IB. Int J Mol Sci 2021;22:7455.
   PubMed Web of Science ®Google Scholar
• Ottaviani A, Iacovelli F, Fiorani P, Desideri A. Natural compounds as therapeutic agents: the case of human topoisomerase ib. Int J Mol Sci 2021;22:4138.
   PubMed Web of Science ®Google Scholar
• Vieira S, Castelli S, Falconi M, et al. Role of 13-(di)phenylalkyl berberine derivatives in the modulation of the activity of human topoisomerase IB. Int J Biol Macromol 2015;77:68–75.
   PubMed Web of Science ®Google Scholar
• Foto E, Özen Ç, Zilifdar F, et al. Benzoxazines as new human topoisomerase I inhibitors and potential poisons. DARU, J Pharm Sci 2020;28:65–73.
   Web of Science ®Google Scholar
• Vutey V, Castelli S, D’Annessa I, et al. Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complex. Arch Biochem Biophys 2016;606:34–40.
   PubMed Web of Science ®Google Scholar
• León IE, Cadavid-Vargas JF, Tiscornia I, et al. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model. J Biol Inorg Chem 2015;20:1175–91.
   PubMed Web of Science ®Google Scholar
• Jain C, Majumder H, Roychoudhury S. Natural compounds as anticancer agents targeting DNA topoisomerases. Curr Genomics 2016;18:75–92.
   Web of Science ®Google Scholar
• Bohlin L, Göransson U, Alsmark C, et al. Natural products in modern life science. Phytochem Rev 2010;9:279–301.
   PubMed Web of Science ®Google Scholar
• David B, Wolfender JL, Dias DA. The pharmaceutical industry and natural products: historical status and new trends. Phytochem Rev 2015;14:299–315.
   Web of Science ®Google Scholar
• Shilling AJ, Witowski CG, Maschek JA, et al. Spongian diterpenoids derived from the antarctic sponge Dendrilla antarctica are potent inhibitors of the leishmania parasite. J Nat Prod 2020;83:1553–62.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ouyang H, Tesauro C, et al. Real-time analysis of cleavage and religation activity of human topoisomerase 1 based on ternary fluorescence resonance energy transfer DNA substrate. Arch Biochem Biophys 2018;643:1–6.
   PubMed Web of Science ®Google Scholar
• Dexheimer TS, Pommier Y. DNA cleavage assay for the identification of topoisomerase I inhibitors. Nat Protoc 2008;3:1736–50.
   PubMed Web of Science ®Google Scholar
• Wu N, Wu XW, Agama K, et al. A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells. Biochemistry 2010;49:10131–6.
   PubMed Web of Science ®Google Scholar
• Fiorani P, Tesauro C, Mancini G, et al. Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant. Nucleic Acids Res 2009;37:6849–58.
   PubMed Web of Science ®Google Scholar
• Dias DA, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites 2012;2:303–36.
   PubMedGoogle Scholar
• Malvicini M, Gutierrez-Moraga A, Rodriguez MM, et al. A tricin derivative from Deschampsia antarctica Desv. Inhibits colorectal carcinoma growth and liver metastasis through the induction of a specific immune response. Mol Cancer Ther 2018;17:966–76.
   PubMed Web of Science ®Google Scholar
• Chowdhury SR, Majumder HK. DNA topoisomerases in unicellular pathogens: structure, function, and druggability. Trends Biochem Sci 2019;44:415–32.
   PubMed Web of Science ®Google Scholar
• Tesauro C, Simonsen AK, Andersen MB, et al. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study. BMC Cancer 2019;19:1158–15.
   PubMed Web of Science ®Google Scholar